Source: Annual Congress 2001 - From noninvasive to invasive treatment strategies for different degrees of acute respiratory failure
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
B. Wartner, T. Mueller, M. Pfeifer, G. Riegger (Regensburg, Germany). Two cases of clinically diagnosed ARDS, first treated as acute atypical pneumonia, caused by noninfectious acute mitral regurgitation. Eur Respir J 2001; 16: Suppl. 31, 1635

Member's Comments

No comment yet.

Related content which might interest you: NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded) Source: Eur Respir Mon; 2008: 41: 60–71 Year: 2008 Pulmonary function in patients recovering from severe acute respiratory syndrome (SARS) Source: Eur Respir J 2004; 24: Suppl. 48, 239s Year: 2004 Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia Source: Eur Respir J 2013; 41: 402-409 Year: 2013 Acute heart failure and fatal arrythmia in severe pneumonias, caused by influenza A(H1N1pdm09) virus Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019 Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome Source: Eur Respir J 2004; 23: 802-804 Year: 2004 The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients? Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients Year: 2015 Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 518s Year: 2005 Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Fatal acute exacerbation of idiopathic pulmonary fibrosis: report of 4 cases Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007 Prognosis after severe chronic obstructive pulmonary disease exacerbation treated with non invasive ventilation Source: Annual Congress 2009 - New trends in noninvasive ventilation for acute respiratory failure Year: 2009 Evaluation of incidental exacerbation of interstitial pneumonia in patients with non-respiratory diseases Source: International Congress 2017 – Rare diseases Year: 2017 Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Features of patients newly diagnosed pulmonary embolism during COVID pneumonia Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021 Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients Source: Eur Respir J 2012; 39: 855-861 Year: 2012 Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy Source: Eur Respir J, 54 (1) 1802442; 10.1183/13993003.02442-2018 Year: 2019 Cryptogenic organizing pneumonia (COP) as a cause of severe acute respiratory failure Source: Eur Respir J 2004; 24: Suppl. 48, 507s Year: 2004 Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021